[Meta-analysis of postoperative adjuvant chemotherapy for Dukes' B colorectal carcinoma].
Ai Zheng
; 24(5): 600-4, 2005 May.
Article
em Zh
| MEDLINE
| ID: mdl-15890106
BACKGROUND & OBJECTIVE: The necessity of adjuvant chemotherapy after radical surgery for patients with Dukes' B (stage II) colorectal carcinoma remains controversial. This study was to evaluate effect of postoperative adjuvant chemotherapy on survival of Dukes' B patients with meta-analysis. METHODS: The results of literatures on postoperative adjuvant chemotherapy for Dukes' B patients from 1985 to 2003 were analyzed synthetically.The 5-year survival rates of postoperative adjuvant chemotherapy group and surgery alone group were compared. RESULTS: Eight published randomized controlled trails were eligible, and had 6 518 patients totally. The 5-year mortality was lower in postoperative adjuvant chemotherapy group than in surgery alone group with odds ratio (OR) of 0.79, and 95% confidence interval (CI) of 0.7-0.9, (P<0.05). CONCLUSION: Postoperative adjuvant chemotherapy could improve 5-year survival rate of Dukes' B patients.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Colorretais
/
Antineoplásicos
Idioma:
Zh
Ano de publicação:
2005
Tipo de documento:
Article